Lucy To
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Lucy To currently works at SAB Biotherapeutics, Inc., as Chief Financial Officer & Executive Vice President from 2024.
Ms. To also formerly worked at Wells Fargo & Co., as MD-Investment Banking Healthcare Group from 2020 to 2024.
Ms. To received her undergraduate degree from Southern Methodist University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 12.08.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| WELLS FARGO & COMPANY | Corporate Officer/Principal | 01.06.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Wells Fargo & Co.
Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen